Philip Morris International (PMI) has announced that it is set to contribute additional funding to support biopharmaceutical company, Medicago to supply up to 76 million doses of its plant-derived COVID-19 vaccine candidate. Medicago, a PMI subsidiary, is a shareholder in a biopharmaceutical company that reached agreements with two departments of the Canadian government to accelerate its COVID-19 vaccine […]
The post PMI to contribute additional funding to support Medicago’s efforts to develop COVID-19 vaccine candidate first appeared on Malawi Nyasa Times - News from Malawi about Malawi.